Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
General product and regulatory information only; this is not medical advice and does not describe how to treat any patient. Regulatory text and FDA database records were checked on 2026-10-31.
Short answer
Shortwave diathermy is a physical medicine device that applies radiofrequency energy at 13.56 MHz or 27.12 MHz to specific areas of the body. In the United States, 21 CFR 890.5290 covers two kinds: devices intended to generate deep heat within tissue, and prescription nonthermal pulsed devices. All are Class II.
Definition and scope
The FDA’s definition sits in 21 CFR 890.5290, “Shortwave diathermy.” Paragraph (a) describes a device that applies electromagnetic energy to specific areas of the body in the radiofrequency bands of 13.56 megahertz (MHz) or 27.12 MHz, intended to generate deep heat within body tissues for selected medical conditions “such as relief of pain, muscle spasms, and joint contractures, but not for the treatment of malignancies.”
The same section has a second category in paragraph (b), “Nonthermal shortwave therapy.” This is a prescription device that applies pulsed electromagnetic energy in the same two RF bands, intended for adjunctive use in the palliative treatment of postoperative pain and edema of soft tissue “by means other than the generation of deep heat.”
The regulation sits in 21 CFR Part 890 (Physical Medicine Devices), Subpart F, Physical Medicine Therapeutic Devices. It is a device classification, not a treatment protocol. See what counts as a medical device for the wider framework.
How it is classified and described in practice
The regulation defines the device by its energy, frequency and intended effect. That is the information a clinic or lab reads from a device record. FDA’s classification database lists three product codes under regulation number 890.5290 (openFDA device classification data, last updated 2026-10-19). They are compared in the table below.
Types and related concepts
The three FDA product codes under 890.5290
| Product code | FDA device name | Class | Source detail |
|---|---|---|---|
| IMJ | Diathermy, Shortwave, For Use In Applying Therapeutic Deep Heat | 2 | Matches paragraph (a); Class II (performance standards) |
| ILX | Diathermy, Shortwave, For Use Other Than Applying Therapeutic Deep Heat | 2 | Listed under the same regulation number |
| PQY | Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain | 2 | FDA definition: “Nonthermal pulsed electromagnetic energy intended for over-the-counter use for the treatment of pain.” |
Source: openFDA device classification, regulation number 890.5290, and the FDA Product Classification page for code IMJ (see Sources below).
Thermal versus nonthermal: different Class II controls
Both categories are Class II, but the regulation controls them differently. The thermal deep-heat device is Class II “(performance standards).” The nonthermal device is Class II “(special controls),” and paragraph (b)(2) lists them:
- Components that contact the body must be demonstrated to be biocompatible.
- Analysis and testing must show the device is electrically safe and electromagnetically compatible in its intended use environment.
- Non-clinical performance testing must characterize the output waveform, including peak output power, pulse width, pulse frequency, duty cycle, other modulation, average measured output power into the RF antenna or applicator, specific absorption rates in a saline gel test load or other model, and the electric and magnetic fields and deposited energy density.
- A detailed summary of clinical testing pertinent to the device’s intended use.
- Labeling that includes the output characteristics, recommended treatment regimes including duration of use, and a summary of the clinical testing and of adverse events and complications.
- For nonthermal devices marketed before the reclassification, an amendment to their previously cleared 510(k) showing compliance with these special controls.
The reclassification was published at 80 FR 61302 (13 October 2015). For how clearance works, see FDA 510(k) premarket notification.
Related: ultrasonic diathermy is a different regulation
Ultrasonic diathermy is regulated separately, under 21 CFR 890.5300. openFDA lists product codes IMI and PFW as Class 2 and LXF (ultrasonic diathermy for use other than applying therapeutic deep heat) as Class 3. See the CASRAI guide to therapeutic ultrasound and its FDA class.
Where it matters for labs, clinics and supply decisions
A reader checking a device record can use the regulation as a cross-walk. The points below come from the regulation and FDA records cited in Sources:
- Match the product code to the intended effect. IMJ is deep heat, ILX is shortwave use other than deep heat, and PQY is nonthermal over-the-counter pain use. The regulation text for paragraph (b) calls nonthermal devices prescription devices, while FDA’s PQY code is described as indicated for over-the-counter use, so the two should not be treated as interchangeable descriptions.
- Check the frequency. The regulation names 13.56 MHz and 27.12 MHz for both thermal and nonthermal categories.
- For nonthermal devices, expect output data in the labeling. The special controls require labeling to state output characteristics and recommended treatment regimes, so a device description without these is missing items the regulation lists.
- Keep it distinct from ultrasonic diathermy. Different regulation number (890.5300), different codes, and one code at Class 3.
Clinic equipment inventories that mention diathermy are covered in the physical therapy equipment list by FDA class.
Common misunderstandings
“All shortwave devices heat tissue.”
Not under the FDA regulation. Paragraph (b) defines a nonthermal category that works by means other than generating deep heat within body tissues.
“Shortwave and ultrasonic diathermy are the same thing.”
They are different technologies with different regulations: 890.5290 for shortwave (radiofrequency) and 890.5300 for ultrasonic.
“The regulation covers any condition.”
The thermal definition lists pain, muscle spasms and joint contractures as examples and expressly excludes treatment of malignancies. The nonthermal definition is limited to adjunctive palliative treatment of postoperative pain and soft tissue edema.
FAQ
What frequencies does shortwave diathermy use?
21 CFR 890.5290 names the radiofrequency bands of 13.56 MHz and 27.12 MHz for both the deep-heat and the nonthermal categories.
What FDA class is a shortwave diathermy device?
Class II. The deep-heat category is Class II (performance standards); the nonthermal category is Class II (special controls). openFDA lists IMJ, ILX and PQY all as class 2.
Does shortwave diathermy treat cancer?
The regulation’s definition of the deep-heat device states it is “not for the treatment of malignancies.”
Sources
- 21 CFR 890.5290, Shortwave diathermy, text via Cornell LII’s eCFR mirror: law.cornell.edu/cfr/text/21/890.5290, checked 2026-10-31.
- openFDA device classification, regulation number 890.5290 and 890.5300: api.fda.gov device classification (data last updated 2026-10-19), checked 2026-10-31.
- FDA Product Classification, code IMJ: accessdata.fda.gov product classification, checked 2026-10-31.







